Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Aug 28.
Published in final edited form as: Mol Neurobiol. 2012 Feb 12;45(2):225–233. doi: 10.1007/s12035-012-8240-6

Functional Heterogeneity of Arcuate Nucleus Pro-Opiomelanocortin Neurons: Implications for Diverging Melanocortin Pathways

Jong-Woo Sohn 1, Kevin W Williams 1
PMCID: PMC3755591  NIHMSID: NIHMS506633  PMID: 22328135

Abstract

Arcuate nucleus (ARC) pro-opiomelanocortin (POMC) neurons are essential regulators of food intake, energy expenditure, and glucose homeostasis. POMC neurons integrate several key metabolic signals that include neurotransmitters and hormones. The change in activity of POMC neurons is relayed to melanocortin receptors in distinct regions of the central nervous system. This review will summarize the role of leptin and serotonin receptors in regulating the activity of POMC neurons and provide a model in which different melanocortin pathways regulate energy and glucose homeostasis.

Keywords: Melanocortin, Leptin, Serotonin, Segregation, Insulin, Energy expenditure, Body weight, Adiposity, Hyperglycemia, TRPC, PI3K

Introduction

The prevalence of obesity and type 2 diabetes poses an enormous health risk worldwide. A recent report demonstrated that the incidences of both diseases have experienced rapid growth over the last two decades [1]. Not surprisingly, in order to treat diseases like obesity, diabetes, and associated comorbidities, researchers have been developing novel strategies to better understand the underlying mechanisms regulating energy and glucose metabolism. Recent insights have focused on the identification of the circuits within the central nervous system that are responsible for regulating energy and glucose homeostasis. The adipose-derived peptide leptin and the neurotransmitter serotonin both have profound effects on energy and glucose homeostasis. The current review summarizes recent findings on distinct roles of leptin and serotonin in a subset of neurons located in the arcuate nucleus of the mediobasal hypothalamus called pro-opiomelanocortin (POMC) neurons. This review will also outline a model of a distributed cellular network for leptin, serotonin, and melanocortin receptors within the central nervous system which may contribute to the regulation of glucose and energy homeostasis.

The Arcuate Nucleus: a Key Site for the Regulation of Energy and Glucose Homeostasis

The mediobasal hypothalamus is critical in regulating food intake and body weight [2-4]. The arcuate nucleus of the hypothalamus (ARC), which includes the POMC and agouti-related peptide (AgRP) neurons, is arguably the most-studied brain region as it relates to the neural control of food intake and body weight. POMC is a gene that encodes a precursor polypeptide which undergoes posttranslational processing giving rise to several peptides called melanocortins. The melanocortins are involved in a variety of biological activities. For example, the melanocortin neuropeptide α-melanocyte-stimulating hormone (α-MSH) is an melanocortin 3 and 4 receptor (MC3R and MC4R) agonist which along with its analogs has been shown to potently inhibit food intake via activation of melanocortin neurons within the central nervous system [5-8]. Neurons expressing AgRP, the inverse agonist (functional antagonist) of melanocortin receptors, are located adjacent to ARC POMC neurons. Importantly, AgRP neurons exclusively colocalize with neuropeptide Y (NPY) in the arcuate nucleus [9-12]. NPY has been associated with several biological activities including learning and memory, nociception, and epilepsy [13,14]; however, NPY has a primary role of stimulating food intake and regulating energy expenditure [15]. Not surprisingly, both POMC and NPY/AgRP neurons integrate various hormones and neurotransmitters, such as leptin, insulin, and serotonin, which are important in the regulation of energy and glucose homeostasis (Fig. 1a) and reviewed here [16,17]. Thus, both α-MSH and NPY/AgRP serve as potent modulators of food intake and body weight.

Fig. 1.

Fig. 1

The arcuate nucleus integrates a variety of metabolic and neuronal signals which are relayed within the central nervous system to regulate energy and glucose homeostasis. a Leptin and insulin are peripheral hormones which influence energy and glucose homeostasis via actions within the arcuate nucleus. The neurotransmitter serotonin also influences the activity of neurons within the arcuate nucleus. These signals ultimately influence distinct central nuclei downstream of the arcuate nucleus which also express melanocortin receptors. Importantly, many of these downstream targets have recently been demonstrated to be direct targets of these same metabolic and neuronal signals, thus establishing a distributed network of neurons responsible for energy and glucose balance. ARC arcuate nucleus, DR dorsal raphe nucleus, DVC dorsal vagal complex, IML intermediolateral column of spinal cord, LHA lateral hypothalamic nucleus, PVN paraventricular hypothalamic nucleus, β pancreatic β-cell. b Leptin receptors (LepRs) on POMC neurons have been shown to increase energy expenditure resulting in a reduction of body weight independent of changes in food intake. Moreover, LepRs on POMC neurons are required for glucose regulation. Opposite to the effects of LepRs on POMC neurons, serotonin 2 C receptors (5-HT2CRs) decrease food intake resulting in a reduction in body weight independent of changes in energy expenditure. Selective reexpression of 5-HT2CRs in POMC neurons also restores hepatic insulin resistance found in mice deficient of 5-HT2CRs

Prior work demonstrated via the use of conventional knockout models that loss of POMC or the MC3Rs and MC4Rs resulted in hyperphagia and obesity [18-21]. Interestingly, mice deficient for AgRP and/or NPY demonstrated normal food intake, body weight, and adiposity [22]. Similarly, toxin-induced ablation of AgRP/NPY neurons early in development resulted in modest effects on food intake [23,24]. However, toxin-induced ablation of AgRP neurons in adults resulted in a rapid suppression of food intake [23]. A parallel study also demonstrated that in adult mice ablation of POMC neurons or NPY/AgRP neurons resulted in acutely increased or decreased food intake, respectively [25]. These data suggested that although developmental loss of the peptides NPY/AgRP or the NPY/AgRP neurons entirely may lead to developmental mechanisms compensating for the alterations in food intake, mature POMC and NPY/AgRP neurons are important in the regulation of food intake and energy homeostasis. Two studies recently extended these observations and reinforced an acute role for POMC and NPY/AgRP neurons in the regulation of feeding behavior. Aponte et al. [26] used optogenetics to demonstrate that stimulation of ARC POMC neurons suppressed feeding, while stimulating AgRP neurons increased food intake in adult mice. The authors also found that the POMC-induced suppression of food intake required melanocortin signaling; however, the AgRP-induced hyperphagia was independent of melanocortin activity. These data importantly demonstrated that acute stimulation of ARC POMC or AgRP neurons directly regulates food intake. Moreover, these data highlight an important role for other signals released by AgRP neurons in feeding behavior. A parallel study by Krashes and colleagues used designer receptors exclusively activated by designer drugs (DREADD) in order to assess the role of AgRP neurons in energy balance and feeding behavior [27]. Stimulation of AgRP neurons profoundly increased food intake and decreased energy expenditure. Not surprisingly, these deficits in energy balance ultimately led to increased body weight and adiposity. Importantly, the elevated food intake and body weight could be normalized by removal of the DREADD activator. Conversely, inhibition of AgRP cellular activity in hungry mice resulted in a reduction of food intake. Notably, stimulating AgRP neurons of animals fed an ad libitum diet failed to influence locomotor activity; however, stimulation of AgRP neurons in the absence of food resulted in a striking increase of locomotor activity. Together these data highlight an important role for POMC and NPY/AgRP neurons in the regulation of food intake and further suggest that NPY/AgRP neurons regulate motivations associated with food-seeking behaviors.

In addition to regulating energy balance, feeding behavior, and locomotor activity; recent evidence has shown that modulation of POMC and NPY/AgRP local circuits in the mediobasal hypothalamus may also contribute to glucose balance [28-32]. However it has been unclear whether this regulation is acute or depends more on genomic changes and whether the activity of POMC neurons alone or NPY/AgRP neurons also influences peripheral glucose production/reuptake. Similarly, POMC and NPY/AgRP neurons have been implicated in the physiology of addiction and reward; however, exactly how and to what extent these neurons influence these behaviors is unclear [17,33,34]. Thus these studies provide a framework for several exciting areas of future investigation and will undoubtedly extend our current understanding on the various roles of the melanocortin circuit.

Intrinsic and Extrinsic Regulation of ARC POMC and NPY/AgRP Neurons by Leptin

The adipocyte-derived hormone leptin and its receptors (LepRs) ameliorate hyperphagia and obesity [35-37]. Mice which lack leptin (ob/ob) or LepRs (db/db) are markedly hyperphagic and obese as well as associated with other abnormalities including diabetes, infertility, impaired growth, high bone mass, and hypercorticosteronemia [37-41]. Interestingly, intracerebroventricular injections of leptin recapitulated the effect of peripheral leptin injections to reduce food intake and body weight [35,42,43]. In addition, the obese phenotype observed in mice lacking LepRs in neurons mirrored the obesity observed in db/db mice [44]. Together these data suggested that most of leptin’s effects are mediated by LepRs within central nervous system [45].

Subsequent studies attempted to identify the specific brain regions mediating leptin effects. Given the role of ARC POMC neurons in regulating feeding behavior and body weight, the requirement of LepRs in POMC neurons was first tested using the cyclization recombination locus of X over P1 technology to delete LepRs only in POMC neurons [46]. Mice lacking LepRs specifically in POMC neurons were obese; however, the obesity was significantly less than that observed in db/db mice. This modest obesity resulted from decreased energy expenditure leading to increased fat mass, while surprisingly hyperphagia was not observed in these mice [47]. Notably, deletions of LepRs in SF-1 neurons of the ventromedial hypothalamic nucleus (VMH) also led to obesity, and the obesity was additive when LepRs were deleted from both POMC and SF-1 neurons [48,49]. Moreover, deficiency of LepRs in AgRP neurons resulted in decreased locomotor activity and modest obesity [50]. Again, concomitant deletion of LepRs in POMC and AgRP neurons lead to an additive effect on body weight and unmasks a striking hyperphagic phenotype. Interestingly, leptin partially reduced food intake in mice deficient for LepRs in AgRP and POMC neurons, supporting a role for leptin to regulate food intake outside of the ARC POMC and NPY/AgRP neurons [50]. These results suggested that the central effects of leptin require ARC POMC neurons; however, LepRs are also required in multiple nuclei, including but not limited to ARC NPY/AgRP and VMH SF1 neurons, for the regulation of glucose and energy balance [17]. A more recent study examined the requirement of LepRs in the nucleus tractus solitarius (NTS) of the caudal medulla. Mice deficient for LepRs within the NTS exhibited an increased rate of weight change over time and hyperphagia [51]. These data are in agreement with a separate study in which LepRs were knocked down in the rat hindbrain resulting in increased body weight [52]. Collectively, these data support a role for LepRs in the NTS to regulate body weight and feeding behavior. Thus, although POMC and NPY/AgRP neurons are important contributors to the central effects of leptin, these recent data support a distributed network of neurons which contribute to the various beneficial effects of leptin.

The cellular mechanisms and network properties of leptin action on POMC neurons has been intensely studied by many groups. Leptin has been shown to activate multiple signaling cascades resulting in acute changes of neuronal activity as well as long-term genomic regulation ultimately contributing to different facets of energy and glucose balance [17]. Initial reports suggested that leptin acutely hyperpolarized an unidentified neuronal population in the mediobasal hypothalamus [53,54]. Subsequent studies suggested that leptin hyperpolarized NPY/AgRP neurons in the ARC while depolarizing ARC POMC neurons and VMH SF1 neurons [48,55-58]. Upon further examination, the leptin-induced depolarization of ARC POMC neurons was shown to be concomitant with the activation of a nonselective cation conductance which was more recently identified as a transient receptor potential C (TRPC) channel [57-59]. In addition, the inhibition of adjacent NPY/AgRP neurons by leptin suppressed GABAergic inputs to ARC POMC neurons which may provide an indirect activation of ARC POMC neurons [58,60]. Importantly, leptin failed to depolarize ARC POMC neurons which were deficient for phosphatitylinositol-3-kinase (PI3K) regulatory subunits, p85α and p85β (Fig. 1b). Moreover, energy balance in response to high fat diet was not affected by the deficiency of both p85α and p85β regulatory subunits [57]. These results suggested that PI3K in POMC neurons exclusively mediate the acute anorexigenic effects of leptin, while the long-term effects of leptin to regulate energy expenditure and glucose balance may be mediated by the other prevalent signaling pathways [57,61-63]. However, a recent report suggested that the segregation of such pathways may not be as clear cut. A separate group recently demonstrated that the catalytic PI3K subunit, p110β, but not p110α is required for the leptin-induced depolarization of ARC POMC neurons [61]. Moreover, the anorexigenic effect of leptin was absent in POMC p110β null mice. Interestingly, selective deletion of p110β from POMC cells resulted in central leptin resistance, increased adiposity, and diet-induced obesity, while POMC p110α null mice experienced minor energy expenditure deficits except when exposed to HFD. Together these data suggest that there may be an underappreciated role of PI3K signaling in the regulation of energy homeostasis in ARC POMC neurons.

Recent work has also suggested that indirect regulation of POMC neurons may play a far larger role in the regulation of energy balance than previously expected. Specifically, NPY/AgRP colocalize with GABA in synaptic boutons which synapse onto ARC POMC neurons, supporting a model in which NPY/AgRP neuronal activity may provide an indirect regulation of ARC POMC neurons [58,60,64]. In addition to NPY/AgRP/GABA neurons, glutamatergic neurons in the adjacent VMH have been shown to project to POMC neurons [65], adding an additional level of complexity to the indirect regulation of POMC neurons via hypothalamic local circuitry. Importantly, Vong et al. [66] recently demonstrated that leptin action on non-AgRP GABAergic neurons prevents obesity to a far greater extent than leptin action on glutamatergic neurons. Moreover, the authors demonstrated that leptin reduces the inhibitory tone on ARC POMC neurons, and this disinhibition probably mediates, at least in part, leptin’s antiobesity effects. Thus, understanding the regulation of POMC neurons has been greatly facilitated by the recruitment of genetically modified mouse models. Moreover, evidence from recent studies demonstrated that many aspects of energy and glucose homeostasis are regulated by POMC neurons but importantly other chemically identified neurons in the central nervous system also contribute to the leptin-induced regulation of energy and glucose balance.

ARC POMC and NPY/AgRP Neurons: Important Cellular Targets of Serotonin

Serotonin (5-hydroxytryptamine; 5-HT) regulates energy and glucose homeostasis via actions in the central nervous system [67,68]. Increased release and/or reduced reuptake of serotonin have been shown to underlie the antiobesity effects of several serotonergic pharmacological agents [69,70]. Specifically, fenfluramine (d-FEN) was a very effective and successful antiobesity drug before it was removed from the market due to serious cardiopulmonary side effects including valvular heart diseases and pulmonary hypertension [71]. Recent studies have suggested that the antiobesity effects of serotonin and serotonergic agents like d-FEN require serotonin 2C receptors (5-HT2CRs). For example, global deletion of 5-HT2CRs led to hyperphagia and obesity [72,73]. In addition, insulin resistance and glucose intolerance were observed in mice lacking 5-HT2CRs [72]. A subsequent study demonstrated that anorexigenic effects of serotonin were mediated in part by the 5-HT2CRs in arcuate nucleus POMC neurons [74]. Interestingly, reexpression of 5-HT2CRs only in POMC neurons reversed the hyperphagia/obesity and insulin resistance observed in 5-HT2CR null mice [75,76]. Similar to the effects of leptin on POMC neurons, serotonin stimulates ARC POMC neurons resulting in the release of α-MSH and subsequent activation of the central melanocortin pathway [64,74,77]. Thus, available data suggest that the effects of serotonin on energy and glucose homeostasis are mediated in part by the 5-HT2CRs in POMC neurons and the activation of melanocortin signaling.

A recent study described a 5-HT2CR-induced suppression of GABAB-activated G protein-gated inwardly rectifying K+ (GIRK) channels in guinea pig POMC neurons [78]. These data supported a possible role for GIRKs in the 5-HT2CRs-induced activation of ARC POMC neurons; however, the cellular mechanisms underlying the activation of POMC neurons by 5-HT2CRs have been unknown. Sohn et al. [79] recently extended these initial observations and found that 5-HT2CR agonists blunted a GABAB-induced GIRK conductance in murine POMC neurons, which was similar to the results obtained in guinea pig. However, POMC neurons from GIRK1 knockout mice were still depolarized by 5-HT2CRs [79], and further experiments demonstrated that activation of 5-HT2CRs stimulates a phospholipase C (PLC)-mediated activation of the TRPC channels which ultimately led to a depolarization of POMC neurons (Fig. 1b). Importantly, prior work has suggested that 5-HT2CRs specifically in POMC neurons mediate the anorexigenic effects of serotonin [76]; thus, these data may provide a cellular correlate to the acute effects of serotonin to reduce food intake.

Opposite to the effects of serotonin on ARC POMC neurons, ARC NPY/AgRP neurons are inhibited by serotonin via activation of serotonin 1B receptors (5-HT1BRs) [64]. Although the cellular mechanisms underlying the inhibition of NPY/AgRP neurons by 5-HT1BRs is still uncertain, the 5-HT1BR-induced inhibition of NPY/AgRP neurons is believed to contribute at least in part to the suppression of inhibitory inputs to adjacent ARC POMC neurons [64]. Heisler et al. also demonstrated that acute administration of 5-HT1BR agonists reduced food intake in a melanocortin-dependent manner. Moreover, recent work suggests that most but not all of the anorexigenic effects of d-FEN are mediated via 5-HT2cRs in POMC neurons and downstream MC4Rs in the paraventricular nucleus and/or amygdala, thus supporting a partial role for 5-HT1BRs in the serotonin-induced anorexia [80]. As highlighted by the recent work of the Lowell and Elmquist laboratories, this potential indirect regulation of ARC POMC neurons by serotonin may be an important mechanism to disinhibit/activate POMC neurons and thus might contribute to the anorexigenic effects of serotonin in the central nervous system. Although much progress has been made, future studies will undoubtedly expand our current understanding of how 5-HT1BRs on ARC NPY/AgRP neurons may ultimately regulate energy and glucose balance.

Central Melanocortin Pathways Differentially Regulate Energy and Glucose Balance

Cone and Colleagues first cloned the melanocortin receptors and defined the melanocortin receptors (MC3R/MC4R) in the regulation of energy and glucose homeostasis [5,17,81]. Although mice deficient for MC3Rs are modestly obese, mice deficient for MC4Rs exhibit profound obesity with marked hyperphagia, hyperglycemia, and hyperinsulinemia even on a chow diet [21]. Importantly, mutations in MC4Rs result in a similar obesity syndrome in humans and is now recognized as the most common monogenic form of human obesity described to date [82-85].

Activity-dependent release of α-MSH from POMC neurons activates MC3Rs and MC4Rs and results in a potent inhibition of food intake [5-8]. Importantly, MC4Rs are expressed by distinct central nuclei in rodents [86,87]. In order to delineate a role of MC4Rs in these CNS nuclei, recent studies have relied on genetic manipulations within several regions involved in the regulation of energy and glucose balance. Two recent studies used mouse models which expressed a loxP-modified, null MC4R allele [88,89]. Expression of Cre recombinase restored the endogenous expression of the MC4R allele selectively where Cre recombinase is expressed. The first study targeted MC4Rs primarily in the paraventricular hypothalamus (PVH) and a subpopulation of neurons in the amygdala [88]. Restoration of MC4R expression specifically in the PVH and the amygdala prevented the majority of the obesity observed in MC4R null mice. Importantly, reexpression of MC4Rs specifically in PVH and amygdala completely rescued the hyperphagia observed in MC4R null mice. Interestingly, these findings agreed with a previous observation that hyperphagia and obesity resulted from the haploinsufficiency of sim1 gene, which is a transcription factor regulating PVH development [90]. However, no apparent changes in energy expenditure were observed in these mice. Together, these findings suggest an important role of sim1 and MC4Rs expressed in the PVH and/or amygdala in regulating food intake and body weight independent of alterations in energy expenditure.

A subsequent study used a mouse model to study the role of MC4Rs within all cholinergic neurons as well as another mouse model to study the role of MC4Rs specifically in cholinergic neurons of the hindbrain which included neurons of the NTS and the dorsal motor nucleus of the vagus nerve [89]. Restoration of the endogenous MC4Rs in all cholinergic neurons normalized body weight and energy expenditure without altering food intake. Moreover, hyperglycemia and hyperinsulinemia was normalized while hepatic insulin action and insulin-mediated suppression of hepatic glucose production showed improvement. Although restoration of MC4Rs in hindbrain cholinergic neurons was sufficient to attenuate hyperinsulinemia; hyperglycemia was only modestly affected and energy expenditure and body weight remained unchanged. These findings suggest a dissociation of melanocortin signaling as it relates to feeding behavior and energy and glucose homeostasis, and thus supports the concept that distinct melanocortin pathways may differentially contribute to these homeostatic modalities.

A Role for POMC Neuronal Heterogeneity

Interestingly, an increase in serum leptin results in both an increase in POMC gene expression and the neuropeptide α-MSH [91-93]. Although, it is intriguing that selective deletion of LepRs in POMC neurons fails to affect food intake [46], acute pharmacological administration of leptin results in a reduction in food intake and body weight which may be mediated at least in part via PI3K activity within ARC POMC neurons [57]. On the other hand, reexpression of 5-HT2CRs in POMC neurons reversed the hyperphagia observed in 5-HT2CR null mice [76]. These findings suggest that LepRs and 5-HT2CRs have distinct roles in POMC neurons and until recently it has been unclear whether these divergent effects are mediated by similar or distinct POMC neurons. A recent paper demonstrated that POMC neurons were activated by either leptin or 5-HT2CRs agonists, however not a single ARC POMC neuron was activated by both peptides [79]. These data suggest that the acute effects of leptin and 5-HT2CR agonists are anatomically segregated in ARC POMC neurons (Fig. 1b). Importantly, POMC neuronal heterogeneity was recently introduced by the demonstration that the acute effects of leptin and insulin were segregated to distinct subpopulations of ARC POMC neurons [94]. These data were further supported by a separate study which reported that while the segregation of the acute leptin and insulin effects on POMC neurons may not be absolute, a subpopulation of ARC POMC neurons acutely responded to leptin but not insulin [61]. Taken together, these data potentially support three functionally heterogeneous POMC neuronal subpopulations.

What is the physiological significance of heterogeneous POMC neurons? As outlined in the current review, LepRs in ARC POMC neurons are required for the regulation of body weight, energy expenditure, and glucose balance; however, direct leptin action on POMC neurons fails to significantly influence feeding behavior. Opposite to the requirement of LepRs, 5-HT2CRs expressed by ARC POMC neurons are required for the regulation of body weight, insulin sensitivity, and food intake; however, energy expenditure seems to be unaffected by 5-HT2CRs in POMC neurons. Additionally, MC4Rs in the PVH and/or amygdala are important in the regulation of feeding behavior which contributes to body weight, while MC4Rs in cholinergic neurons regulate body weight and energy expenditure without altering food intake. Moreover, MC4Rs in cholinergic neurons are involved in the regulation of glucose and insulin levels as well as hepatic insulin action. MC4Rs in cholinergic neurons also regulate hepatic insulin resistance; an effect shared with MC4Rs in hindbrain cholinergic neurons. Together these data suggest that leptin and serotonin may alter the activity of a distinct heterogeneous population of ARC POMC neurons which may ultimately be coupled to diverging melanocortin pathways that regulate energy and glucose homeostasis (Fig. 1b).

Summary

POMC neurons of the arcuate nucleus are direct targets of various hormones and neurotransmitters. The effects of leptin and serotonin in energy and glucose homeostasis are mediated at least in part by the LepRs and 5-HT2CRs expressed by POMC neurons. Recently, the cellular mechanisms for regulating the activity of POMC neurons by these receptors were identified. Both LepRs and 5-HT2CRs in POMC neurons are critical regulators of body weight and glucose balance; however, recent work has described a divergent role for these peptides in ARC POMC neurons as it relates to the underlying alterations of energy and glucose metabolism. Moreover, recent studies suggest all POMC neurons are not identical but several heterogeneous POMC neuronal populations exist. The possibility that different subpopulations of POMC neurons may constitute distinct melanocortin pathways is an exciting area for future investigation.

Acknowledgments

We gratefully acknowledge Joel K. Elmquist D.V. M, Ph.D. for insightful comments on this review. This work was supported by the American Diabetes Association (7-11-MN-16) to J.-W.S. and the National Institutes of Health (K01 DK087780) to KWW.

References

  • 1.Trust for America’s Health TRWJF . F as in fat: how obesity threatens America’s future. Trust for America’s Health; Washington (DC): 2011. [Google Scholar]
  • 2.Hetherington AW, Ranson SW. Hypothalamic lesions and adiposity in the rat. Anat Rec. 1940;78(2):149–172. [Google Scholar]
  • 3.Debons AF, Silver L, Cronkite EP, Johnson HA, Brecher G, Tenzer D, Schwartz IL. Localization of gold in mouse brain in relation to gold thioglucose obesity. Am J Physiol. 1962;202:743–750. doi: 10.1152/ajplegacy.1962.202.4.743. [DOI] [PubMed] [Google Scholar]
  • 4.Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969;164(880):719–721. doi: 10.1126/science.164.3880.719. [DOI] [PubMed] [Google Scholar]
  • 5.Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 1997;385(6612):165–168. doi: 10.1038/385165a0. [DOI] [PubMed] [Google Scholar]
  • 6.Tsujii S, Bray GA. Acetylation alters the feeding response to MSH and beta-endorphin. Brain Res Bull. 1989;23(3):165–169. doi: 10.1016/0361-9230(89)90142-1. [DOI] [PubMed] [Google Scholar]
  • 7.Rossi M, Kim MS, Morgan DG, Small CJ, Edwards CM, Sunter D, Abusnana S, Goldstone AP, Russell SH, Stanley SA, Smith DM, Yagaloff K, Ghatei MA, Bloom SR. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology. 1998;1/39(10):4428–4431. doi: 10.1210/endo.139.10.6332. [DOI] [PubMed] [Google Scholar]
  • 8.Ludwig DS, Mountjoy KG, Tatro JB, Gillette JA, Frederich RC, Flier JS, Maratos-Flier E. Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am J Physiol. 1998;274(4 Pt 1):E627–633. doi: 10.1152/ajpendo.1998.274.4.E627. [DOI] [PubMed] [Google Scholar]
  • 9.Hahn TM, Breininger JF, Baskin DG, Schwartz MW. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci. 1998;1(4):271–272. doi: 10.1038/1082. [DOI] [PubMed] [Google Scholar]
  • 10.Nijenhuis WA, Oosterom J, Adan RA. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol. 2001;15(1):164–171. doi: 10.1210/mend.15.1.0578. [DOI] [PubMed] [Google Scholar]
  • 11.Tota MR, Smith TS, Mao C, MacNeil T, Mosley RT, Van der Ploeg LH, Fong TM. Molecular interaction of agouti protein and agouti-related protein with human melanocortin receptors. Biochemistry. 1999;38(3):897–904. doi: 10.1021/bi9815602. [DOI] [PubMed] [Google Scholar]
  • 12.Chai BX, Neubig RR, Millhauser GL, Thompson DA, Jackson PJ, Barsh GS, Dickinson CJ, Li JY, Lai YM, Gantz I. Inverse agonist activity of agouti and agouti-related protein. Peptides. 2003;24(4):603–609. doi: 10.1016/s0196-9781(03)00104-9. [DOI] [PubMed] [Google Scholar]
  • 13.Dube C. Neuropeptide Y: potential role in recurrent developmental seizures. Peptides. 2007;28(2):441–446. doi: 10.1016/j.peptides.2006.08.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Smith PA, Moran TD, Abdulla F, Tumber KK, Taylor BK. Spinal mechanisms of NPY analgesia. Peptides. 2007;28(2):464–474. doi: 10.1016/j.peptides.2006.09.029. [DOI] [PubMed] [Google Scholar]
  • 15.Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 1984;115(1):427–429. doi: 10.1210/endo-115-1-427. [DOI] [PubMed] [Google Scholar]
  • 16.Williams KW, Scott MM, Elmquist JK. From observation to experimentation: leptin action in the mediobasal hypothalamus. Am J Clin Nutr. 2009;89(3):985S–990S. doi: 10.3945/ajcn.2008.26788D. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Williams KW, Scott MM, Elmquist JK. Modulation of the central melanocortin system by leptin, insulin, and serotonin: coordinated actions in a dispersed neuronal network. Eur J Pharmacol. 2011;660(1):2–12. doi: 10.1016/j.ejphar.2010.11.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Yaswen L, Diehl N, Brennan MB, Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med. 1999;5(9):1066–1070. doi: 10.1038/12506. [DOI] [PubMed] [Google Scholar]
  • 19.Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, Van der Ploeg LH. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet. 2000;26(1):97–102. doi: 10.1038/79254. [DOI] [PubMed] [Google Scholar]
  • 20.Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD. The central melanocortin system can directly regulate serum insulin levels. Endocrinology. 2000;141(9):3072–3079. doi: 10.1210/endo.141.9.7665. [DOI] [PubMed] [Google Scholar]
  • 21.Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88(1):131–141. doi: 10.1016/s0092-8674(00)81865-6. [DOI] [PubMed] [Google Scholar]
  • 22.Qian S, Chen H, Weingarth D, Trumbauer ME, Novi DE, Guan X, Yu H, Shen Z, Feng Y, Frazier E, Chen A, Camacho RE, Shearman LP, Gopal-Truter S, MacNeil DJ, Van der Ploeg LH, Marsh DJ. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell B/iol. 2002;22(14):5027–5035. doi: 10.1128/MCB.22.14.5027-5035.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Luquet S, Perez FA, Hnasko TS, Palmiter RD. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science. 2005;310(5748):683–685. doi: 10.1126/science.1115524. [DOI] [PubMed] [Google Scholar]
  • 24.Luquet S, Phillips CT, Palmiter RD. NPY/AgRP neurons are not essential for feeding responses to glucoprivation. Peptides. 2007;28(2):214–225. doi: 10.1016/j.peptides.2006.08.036. [DOI] [PubMed] [Google Scholar]
  • 25.Gropp E, Shanabrough M, Borok E, Xu AW, Janoschek R, Buch T, Plum L, Balthasar N, Hampel B, Waisman A, Barsh GS, Horvath TL, Bruning JC. Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci. 2005;8(10):1289–1291. doi: 10.1038/nn1548. [DOI] [PubMed] [Google Scholar]
  • 26.Aponte Y, Atasoy D, Sternson SM. AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat Neurosci. 2011;14(3):351–355. doi: 10.1038/nn.2739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Krashes MJ, Koda S, Ye C, Rogan SC, Adams AC, Cusher DS, Maratos-Flier E, Roth BL, Lowell BB. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J Clin Invest. 2011;121(4):1424–1428. doi: 10.1172/JCI46229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Schwartz MW, Porte D., Jr Diabetes, obesity, and the brain. Science. 2005;307(5708):375–379. doi: 10.1126/science.1104344. [DOI] [PubMed] [Google Scholar]
  • 29.Woods SC, Seeley RJ, Porte D, Jr, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science. 1998;280(5368):1378–1383. doi: 10.1126/science.280.5368.1378. [DOI] [PubMed] [Google Scholar]
  • 30.Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, Zhang CY, Xu C, Vianna CR, Balthasar N, Lee CE, Elmquist JK, Cowley MA, Lowell BB. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature. 2007;449(7159):228–232. doi: 10.1038/nature06098. [DOI] [PubMed] [Google Scholar]
  • 31.Pocai A, Obici S, Schwartz GJ, Rossetti L. A brain-liver circuit regulates glucose homeostasis. Cell Metab. 2005;1(1):53–61. doi: 10.1016/j.cmet.2004.11.001. [DOI] [PubMed] [Google Scholar]
  • 32.Zhou L, Sutton GM, Rochford JJ, Semple RK, Lam DD, Oksanen LJ, Thornton-Jones ZD, Clifton PG, Yueh CY, Evans ML, McCrimmon RJ, Elmquist JK, Butler AA, Heisler LK. Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab. 2007;6(5):398–405. doi: 10.1016/j.cmet.2007.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Saper CB, Chou TC, Elmquist JK. The need to feed: homeostatic and hedonic control of eating. Neuron. 2002;36(2):199–211. doi: 10.1016/s0896-6273(02)00969-8. [DOI] [PubMed] [Google Scholar]
  • 34.Koob G. Drug addiction. Neurobiol Dis. 2000;7(5):543–545. doi: 10.1006/nbdi.2000.0351. [DOI] [PubMed] [Google Scholar]
  • 35.Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995;269(5223):546–549. doi: 10.1126/science.7624778. [DOI] [PubMed] [Google Scholar]
  • 36.Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O’Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New Engl J Med. 1999;341(12):879–884. doi: 10.1056/NEJM199909163411204. [DOI] [PubMed] [Google Scholar]
  • 37.Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–432. doi: 10.1038/372425a0. [DOI] [PubMed] [Google Scholar]
  • 38.Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996;84(3):491–495. doi: 10.1016/s0092-8674(00)81294-5. [DOI] [PubMed] [Google Scholar]
  • 39.Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995;83(7):1263–1271. doi: 10.1016/0092-8674(95)90151-5. [DOI] [PubMed] [Google Scholar]
  • 40.Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996;379(6566):632–635. doi: 10.1038/379632a0. [DOI] [PubMed] [Google Scholar]
  • 41.Chua SC, Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 1996;271(5251):994–996. doi: 10.1126/science.271.5251.994. [DOI] [PubMed] [Google Scholar]
  • 42.Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A. 1997;94(16):8878–8883. doi: 10.1073/pnas.94.16.8878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269(5223):543–546. doi: 10.1126/science.7624777. [DOI] [PubMed] [Google Scholar]
  • 44.Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P, Mombaerts P, Friedman JM. Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest. 2001;108(8):1113–1121. doi: 10.1172/JCI13914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001;104(4):531–543. doi: 10.1016/s0092-8674(01)00240-9. [DOI] [PubMed] [Google Scholar]
  • 46.Balthasar N, Coppari R, McMinn J, Liu SM, Lee CE, Tang V, Kenny CD, McGovern RA, Chua SC, Jr, Elmquist JK, Lowell BB. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron. 2004;42(6):983–991. doi: 10.1016/j.neuron.2004.06.004. [DOI] [PubMed] [Google Scholar]
  • 47.Hill JW, Elias CF, Fukuda M, Williams KW, Berglund ED, Holland WL, Cho YR, Chuang JC, Xu Y, Choi M, Lauzon D, Lee CE, Coppari R, Richardson JA, Zigman JM, Chua S, Scherer PE, Lowell BB, Bruning JC, Elmquist JK. Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab. 2010;11(4):286–297. doi: 10.1016/j.cmet.2010.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Dhillon H, Zigman JM, Ye C, Lee CE, McGovern RA, Tang V, Kenny CD, Christiansen LM, White RD, Edelstein EA, Coppari R, Balthasar N, Cowley MA, Chua S, Jr, Elmquist JK, Lowell BB. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron. 2006;49(2):191–203. doi: 10.1016/j.neuron.2005.12.021. [DOI] [PubMed] [Google Scholar]
  • 49.Bingham NC, Anderson KK, Reuter AL, Stallings NR, Parker KL. Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. Endocrinology. 2008;149(5):2138–2148. doi: 10.1210/en.2007-1200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.van de Wall E, Leshan R, Xu AW, Balthasar N, Coppari R, Liu SM, Jo YH, MacKenzie RG, Allison DB, Dun NJ, Elmquist J, Lowell BB, Barsh GS, de Luca C, Myers MG, Jr, Schwartz GJ, Chua SC., Jr Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology. 2008;149(4):1773–1785. doi: 10.1210/en.2007-1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Scott MM, Williams KW, Rossi J, Lee CE, Elmquist JK. Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in mice. J Clin Invest. 2011;121(6):2413–2421. doi: 10.1172/JCI43703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hayes MR, Skibicka KP, Leichner TM, Guarnieri DJ, DiLeone RJ, Bence KK, Grill HJ. Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation. Cell Metabolism. 2010;11(1):77–83. doi: 10.1016/j.cmet.2009.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Spanswick D, Smith MA, Groppi VE, Logan SD, Ashford ML. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature. 1997;390(6659):521–525. doi: 10.1038/37379. [DOI] [PubMed] [Google Scholar]
  • 54.Spanswick D, Smith MA, Mirshamsi S, Routh VH, Ashford ML. Insulin activates ATP-sensitive K+channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci. 2000;3(8):757–758. doi: 10.1038/77660. [DOI] [PubMed] [Google Scholar]
  • 55.van den Top M, Lee K, Whyment AD, Blanks AM, Spanswick D. Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat Neurosci. 2004;7(5):493–494. doi: 10.1038/nn1226. [DOI] [PubMed] [Google Scholar]
  • 56.Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord. 2001;25(Suppl 5):S63–67. doi: 10.1038/sj.ijo.0801913. [DOI] [PubMed] [Google Scholar]
  • 57.Hill JW, Williams KW, Ye C, Luo J, Balthasar N, Coppari R, Cowley MA, Cantley LC, Lowell BB, Elmquist JK. Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. J Clin Invest. 2008;118(5):1796–1805. doi: 10.1172/JCI32964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411(6836):480–484. doi: 10.1038/35078085. [DOI] [PubMed] [Google Scholar]
  • 59.Qiu J, Fang Y, Ronnekleiv OK, Kelly MJ. Leptin excites proopiomelanocortin neurons via activation of TRPC channels. J Neurosci. 2010;30(4):1560–1565. doi: 10.1523/JNEUROSCI.4816-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Tong Q, Ye CP, Jones JE, Elmquist JK, Lowell BB. Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat Neurosci. 2008;11(9):998–1000. doi: 10.1038/nn.2167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Al-Qassab H, Smith MA, Irvine EE, Guillermet-Guibert J, Claret M, Choudhury AI, Selman C, Piipari K, Clements M, Lingard S, Chandarana K, Bell JD, Barsh GS, Smith AJ, Batterham RL, Ashford ML, Vanhaesebroeck B, Withers DJ. Dominant role of the p110β isoform of PI3K over p110α in energy homeostasis regulation by POMC and AgRP neurons. Cell Metab. 2009;10(5):343–354. doi: 10.1016/j.cmet.2009.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Xu AW, Ste-Marie L, Kaelin CB, Barsh GS. Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding. Endocrinology. 2007;148(1):72–80. doi: 10.1210/en.2006-1119. [DOI] [PubMed] [Google Scholar]
  • 63.Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E, Neel BG, Schwartz MW, Myers MG., Jr STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature. 2003;421(6925):856–859. doi: 10.1038/nature01388. [DOI] [PubMed] [Google Scholar]
  • 64.Heisler LK, Jobst EE, Sutton GM, Zhou L, Borok E, Thornton-Jones Z, Liu HY, Zigman JM, Balthasar N, Kishi T, Lee CE, Aschkenasi CJ, Zhang CY, Yu J, Boss O, Mountjoy KG, Clifton PG, Lowell BB, Friedman JM, Horvath T, Butler AA, Elmquist JK, Cowley MA. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron. 2006;51(2):239–249. doi: 10.1016/j.neuron.2006.06.004. [DOI] [PubMed] [Google Scholar]
  • 65.Sternson SM, Shepherd GM, Friedman JM. Topographic mapping of VMH→arcuate nucleus microcircuits and their reorganization by fasting. Nat Neurosci. 2005;8(10):1356–1363. doi: 10.1038/nn1550. [DOI] [PubMed] [Google Scholar]
  • 66.Vong L, Ye C, Yang Z, Choi B, Chua S, Jr, Lowell BB. Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron. 2011;71(1):142–154. doi: 10.1016/j.neuron.2011.05.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Giorgetti M, Tecott LH. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems. Eur J Pharmacol. 2004;488(1-3):1–9. doi: 10.1016/j.ejphar.2004.01.036. [DOI] [PubMed] [Google Scholar]
  • 68.Heisler LK, Cowley MA, Kishi T, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Zigman JM, Cone RD, Elmquist JK. Central serotonin and melanocortin pathways regulating energy homeostasis. Ann N Y Acad Sci. 2003;994:169–174. doi: 10.1111/j.1749-6632.2003.tb03177.x. [DOI] [PubMed] [Google Scholar]
  • 69.Halford JC, Boyland EJ, Blundell JE, Kirkham TC, Harrold JA. Pharmacological management of appetite expression in obesity. Nat Rev Endocrinol. 2010;6(5):255–269. doi: 10.1038/nrendo.2010.19. [DOI] [PubMed] [Google Scholar]
  • 70.Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, Bays H, Shanahan WR. Multicenter, placebo-controlled trial of lorcaserin for weight management. New Engl J Med. 2010;363(3):245–256. doi: 10.1056/NEJMoa0909809. [DOI] [PubMed] [Google Scholar]
  • 71.Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease associated with fenfluramine-phentermine. New Engl J Med. 1997;337(9):581–588. doi: 10.1056/NEJM199708283370901. [DOI] [PubMed] [Google Scholar]
  • 72.Nonogaki K, Strack AM, Dallman MF, Tecott LH. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med. 1998;4(10):1152–1156. doi: 10.1038/2647. [DOI] [PubMed] [Google Scholar]
  • 73.Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 1995;374(6522):542–546. doi: 10.1038/374542a0. [DOI] [PubMed] [Google Scholar]
  • 74.Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Marcus JN, Holstege H, Lee CE, Cone RD, Elmquist JK. Activation of central melanocortin pathways by fenfluramine. Science. 2002;297(5581):609–611. doi: 10.1126/science.1072327. [DOI] [PubMed] [Google Scholar]
  • 75.Xu Y, Berglund ED, Sohn JW, Holland WL, Chuang JC, Fukuda M, Rossi J, Williams KW, Jones JE, Zigman JM, Lowell BB, Scherer PE, Elmquist JK. 5-HT(2C)Rs expressed by proopiomelanocortin neurons regulate insulin sensitivity in liver. Nat Neurosci. 2010;13(12):1457–1459. doi: 10.1038/nn.2664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Xu Y, Jones JE, Kohno D, Williams KW, Lee CE, Choi MJ, Anderson JG, Heisler LK, Zigman JM, Lowell BB, Elmquist JK. 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron. 2008;60(4):582–589. doi: 10.1016/j.neuron.2008.09.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Lam DD, Przydzial MJ, Ridley SH, Yeo GS, Rochford JJ, O’Rahilly S, Heisler LK. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology. 2008;149(3):1323–1328. doi: 10.1210/en.2007-1321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Qiu J, Xue C, Bosch MA, Murphy JG, Fan W, Ronnekleiv OK, Kelly MJ. Serotonin 5-hydroxytryptamine2C receptor signaling in hypothalamic proopiomelanocortin neurons: role in energy homeostasis in females. Mol Pharmacol. 2007;72(4):885–896. doi: 10.1124/mol.107.038083. [DOI] [PubMed] [Google Scholar]
  • 79.Sohn JW, Xu Y, Jones JE, Wickman K, Williams KW, Elmquist JK. Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels. Neuron. 2011;71(3):488–497. doi: 10.1016/j.neuron.2011.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Xu Y, Jones JE, Lauzon DA, Anderson JG, Balthasar N, Heisler LK, Zinn AR, Lowell BB, Elmquist JK. A serotonin and melanocortin circuit mediates D-fenfluramine anorexia. J Neurosci. 2010;30(44):14630–14634. doi: 10.1523/JNEUROSCI.5412-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science. 1992;257(5074):1248–1251. doi: 10.1126/science.1325670. [DOI] [PubMed] [Google Scholar]
  • 82.Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O’Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348(12):1085–1095. doi: 10.1056/NEJMoa022050. [DOI] [PubMed] [Google Scholar]
  • 83.Barsh GS, Farooqi IS, O’Rahilly S. Genetics of body-weight regulation. Nature. 2000;404(6778):644–651. doi: 10.1038/35007519. [DOI] [PubMed] [Google Scholar]
  • 84.Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet. 1998;20(2):113–114. doi: 10.1038/2407. [DOI] [PubMed] [Google Scholar]
  • 85.Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O’Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet. 1998;20(2):111–112. doi: 10.1038/2404. [DOI] [PubMed] [Google Scholar]
  • 86.Kishi T, Aschkenasi CJ, Lee CE, Mountjoy KG, Saper CB, Elmquist JK. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J Comp Neurol. 2003;457(3):213–235. doi: 10.1002/cne.10454. [DOI] [PubMed] [Google Scholar]
  • 87.Liu H, Kishi T, Roseberry AG, Cai X, Lee CE, Montez JM, Friedman JM, Elmquist JK. Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci. 2003;23(18):7143–7154. doi: 10.1523/JNEUROSCI.23-18-07143.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Ferreira M, Tang V, McGovern RA, Kenny CD, Christiansen LM, Edelstein E, Choi B, Boss O, Aschkenasi C, Zhang CY, Mountjoy K, Kishi T, Elmquist JK, Lowell BB. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell. 2005;123(3):493–505. doi: 10.1016/j.cell.2005.08.035. [DOI] [PubMed] [Google Scholar]
  • 89.Rossi J, Balthasar N, Olson D, Scott M, Berglund E, Lee CE, Choi MJ, Lauzon D, Lowell BB, Elmquist JK. Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell Metabolism. 2011;13(2):195–204. doi: 10.1016/j.cmet.2011.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Michaud JL, Boucher F, Melnyk A, Gauthier F, Goshu E, Levy E, Mitchell GA, Himms-Hagen J, Fan CM. Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum Mol Genet. 2001;10(14):1465–1473. doi: 10.1093/hmg/10.14.1465. [DOI] [PubMed] [Google Scholar]
  • 91.Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes. 1998;47(2):294–297. doi: 10.2337/diab.47.2.294. [DOI] [PubMed] [Google Scholar]
  • 92.Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG. Leptin increases hypothalamic proopiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes. 1997;46(12):2119–2123. doi: 10.2337/diab.46.12.2119. [DOI] [PubMed] [Google Scholar]
  • 93.Thornton JE, Cheung CC, Clifton DK, Steiner RA. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology. 1997;138(11):5063–5066. doi: 10.1210/endo.138.11.5651. [DOI] [PubMed] [Google Scholar]
  • 94.Williams KW, Margatho LO, Lee CE, Choi M, Lee S, Scott MM, Elias CF, Elmquist JK. Segregation of acute leptin and insulin effects indistinct populations of arcuate pro-opiomelanocortin neurons. J Neurosci. 2010;30(7):2472–2479. doi: 10.1523/JNEUROSCI.3118-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES